Hom_ESCs_KO_DNMT3B_Rep1 |
ESCs_KO_DNMT3B_Rep1 |
H1 Human Embryonic Stem Cell (knock DNMT3B out), Replicate 1 |
- |
hg38 |
69.01% |
64.12% |
88.21% |
90.64% |
21.39 |
99.56% |
Hom_EsophagusSquamousEpithelium_53yrs_Female |
EsophagusSquamousEpithelium_53yrs_Female |
Esophagus Squamous Epithelium from 53-year-old female adult |
Female |
hg38 |
71.22% |
66.87% |
87.50% |
81.40% |
22.14 |
99.57% |
Hom_Normal_ESCs_KO_PWWPDomain_Rep1 |
Normal_ESCs_KO_PWWPDomain_Rep1 |
H1 Human Embryonic Stem Cell (knock PWWP domain out), Replicate 1 |
- |
hg38 |
83.52% |
78.02% |
88.29% |
91.04% |
22.33 |
99.52% |
Hom_Normal_ESCs_KO_PWWPDomain_Rep2 |
Normal_ESCs_KO_PWWPDomain_Rep2 |
H1 Human Embryonic Stem Cell (knock PWWP domain out), Replicate 2 |
- |
hg38 |
83.28% |
77.50% |
88.26% |
90.83% |
19.96 |
99.54% |
Hom_Tumor_EsophagealSquamouseCarcinoma_T11N0M0_Rep1 |
Tumor_EsophagealSquamouseCarcinoma_T11N0M0_Rep1 |
Esophageal Squamouse Carcinoma (moderately differentiated tumor pathological stage;T11N0M0), Replicate 1 |
- |
hg38 |
83.67% |
77.86% |
87.60% |
88.99% |
19.18 |
99.61% |
Hom_Tumor_EsophagealSquamouseCarcinoma_T11N0M0_Rep2 |
Tumor_EsophagealSquamouseCarcinoma_T11N0M0_Rep2 |
Esophageal Squamouse Carcinoma (moderately differentiated tumor pathological stage;T11N0M0), Replicate 2 |
- |
hg38 |
85.42% |
79.29% |
87.15% |
88.70% |
22.36 |
99.62% |
Hom_Tumor_EsophagealSquamouseCarcinoma_T11N0M0_Rep3 |
Tumor_EsophagealSquamouseCarcinoma_T11N0M0_Rep3 |
Esophageal Squamouse Carcinoma (highly or moderately differentiated tumor pathological stage;T11N0M0), Replicate 3 |
- |
hg38 |
84.69% |
79.25% |
87.41% |
89.00% |
19.92 |
99.60% |
Hom_Tumor_EsophagealSquamouseCarcinoma_T11N0M0_Rep4 |
Tumor_EsophagealSquamouseCarcinoma_T11N0M0_Rep4 |
Esophageal Squamouse Carcinoma (moderately or poorly differentiated tumor pathological stage;T11N0M0), Replicate 4 |
- |
hg38 |
84.24% |
77.66% |
87.33% |
88.42% |
19.58 |
99.56% |
Hom_Tumor_EsophagealSquamouseCarcinoma_T11N1aM0_Rep1 |
Tumor_EsophagealSquamouseCarcinoma_T11N1aM0_Rep1 |
Esophageal Squamouse Carcinoma (moderately differentiated tumor pathological stage;T11N1aM0), Replicate 1 |
- |
hg38 |
84.36% |
78.47% |
87.76% |
89.32% |
20.40 |
99.61% |
Hom_Tumor_EsophagealSquamouseCarcinoma_T11N1aM0_Rep2 |
Tumor_EsophagealSquamouseCarcinoma_T11N1aM0_Rep2 |
Esophageal Squamouse Carcinoma (moderately differentiated tumor pathological stage;T11N1aM0), Replicate 2 |
- |
hg38 |
85.43% |
79.44% |
87.30% |
88.68% |
20.35 |
99.55% |
Hom_Tumor_EsophagealSquamouseCarcinoma_T1bN0M0 |
Tumor_EsophagealSquamouseCarcinoma_T1bN0M0 |
Esophageal Squamouse Carcinoma (moderately differentiated tumor pathological stage;T1bN0M0) |
- |
hg38 |
85.49% |
79.23% |
87.13% |
88.75% |
18.40 |
99.48% |
Hom_Tumor_EsophagealSquamouseCarcinoma_T2N0aM0 |
Tumor_EsophagealSquamouseCarcinoma_T2N0aM0 |
Esophageal Squamouse Carcinoma (moderately differentiated tumor pathological stage;T2N0aM0) |
- |
hg38 |
83.57% |
77.37% |
87.19% |
88.54% |
22.05 |
99.56% |
Hom_Tumor_EsophagealSquamouseCarcinoma_T2N0M0 |
Tumor_EsophagealSquamouseCarcinoma_T2N0M0 |
Esophageal Squamouse Carcinoma (highly differentiated tumor pathological stage;T2N0M0) |
- |
hg38 |
84.55% |
78.64% |
87.40% |
88.66% |
19.45 |
99.48% |
Hom_Tumor_EsophagealSquamouseCarcinoma_T2N1aM0 |
Tumor_EsophagealSquamouseCarcinoma_T2N1aM0 |
Esophageal Squamouse Carcinoma (highly or moderately differentiated tumor pathological stage;T2N1aM0) |
- |
hg38 |
85.26% |
79.09% |
87.64% |
89.20% |
20.25 |
99.61% |